Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten - Swissmedic Key 61317003 Registration Holder Mepha Pharma AG Name Ibandronat-Mepha 150 mg Monatstabletten, Filmtabletten Date of registration 24.02.2011 Original/Generic Generic Introduction of Sequence 24.02.2011 ATC-Classification Ibandronic Acid (M05BA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.99. Show package size Index Therapeuticus (Swissmedic) 07.99. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 17.23 Limitation Yes Limitation text
Deductible 10 % Consumer price 35.15 Feedback FB Daily cost GTIN 7680613170036 Medication Code Synthetika Pharmacode 7558082 Disponibility
Composition acidum ibandronicum 150 mg ut natrii ibandronas monohydricus, cellulosum microcristallinum, povidonum, crospovidonum, silica colloidalis anhydrica, acidum stearicum, Überzug: E 171, hypromellosum, macrogolum 400, polysorbatum 80, pro compresso obducto corresp. natrium 10.8 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Ibandronic Acid 150 mg
BAG: Active Agent Dose Ibandronic Acid 150 mg
Inactive agents Dose additional_information Acidum Stearicum Cellulosum Microcristallinum Crospovidonum E 171 Überzug Hypromellosum Macrogol 400 Polysorbatum 80 Povidone Pro Compresso Obducto Silica Colloidalis Anhydrica
Source Data was imported : 03.02.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
